CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 64 enrolled
Drug / intervention
Optimal Dosing of Omeprazoledrug
Likely dose
Optimal Dosing of Omeprazole 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02623816
NCT02623816Phase 4Completed
CompareCT.gov

Prospective Study Assessing Patient Satisfaction of Symptom Control With Proton Pump Inhibitor Dosing Regimen

MetroHealth Medical Center·interventional·Posted Dec 8, 2015·Updated Oct 25, 2022

In Brief

A Phase 4 clinical trial evaluating Optimal Dosing of Omeprazole for Heartburn. Completed, enrolled 64 participants across 1 site.

Detailed Summary

The overall aim of this study is to assess if patients with persistent gastroesophageal reflux disease (GERD) symptoms receiving sub-optimal omeprazole dosing experience improvement in GERD symptoms when prescribed an optimal dosing regimen. The optimal dosing regimen is defined as taking omeprazole 30 minutes prior to the first meal of the day.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeartburn
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 8, 2015
Enrollment StartAug 1, 2014
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.6 years ago

Interventions

Optimal Dosing of Omeprazoledrug

Omeprazole 20 mg